Aristolactam BIII, a naturally derived DYRK1A inhibitor, rescues Down syndrome-related phenotypes-Reference-Cited by-同舟云学术

Aristolactam BIII, a naturally derived DYRK1A inhibitor, rescues Down syndrome-related phenotypes

Published:2021-11 Issue: Volume:92 Page:153695
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Choi Miri,Kim Ae-kyeong,Ham Youngwook,Lee Joo-Youn,Kim Daeyong,Yang Ansook,Jo Min Ju,Yoon Eunyoung,Heo Jung-Nyoung,Han Sang-Bae,Ki Min-Hyo,Lee Kyu-Sun,Cho Sungchan

Funder

National Research Foundation of Korea

KRIBB

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference72 articles.

1. Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A);Adayev;Arch. Biochem. Biophys.,2011

2. DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects;Ahn;Neurobiol. Dis.,2006

3. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review;Arlt;Mutagenesis,2002

4. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21;Arron;Nature,2006

5. Epilepsy in children with Down syndrome;Arya;Epileptic Disord.,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer’s disease (AD);Bioorganic & Medicinal Chemistry;2024-09

2. Discovery of a novel chemotype as DYRK1A inhibitors against Alzheimer's disease: Computational modeling and biological evaluation;International Journal of Biological Macromolecules;2024-06

3. Discovery of a Novel Chemotype as DYRK1A Inhibitors against Alzheimer’s disease: Computational Modeling and Biological Evaluation;2023-11-05

4. Divergent synthesis of new naphtho-fused 2-aminoindolines and naphthoxindoles based on straightforward construction of phenanthrene;Green Synthesis and Catalysis;2023-11

5. Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B;Journal of Medicinal Chemistry;2023-07-24